Shattuck Labs STTK
NASDAQ STTK
$6.79 -0.17 (-2.44%)
As of: Sep 4, 2026 · 3:59 PM EDT

Shattuck Labs (STTK) Asset Writedowns and Impairment (2022 - 2025)

Shattuck Labs (STTK) posted quarterly Asset Writedowns and Impairment of $81000.0 for Q4 2025, up 8.0% year-over-year from $75000.0 in Q4 2024, and up 8.0% quarter-over-quarter from $75000.0 in Q4 2024.

Analysis

Shattuck Labs (STTK) Asset Writedowns and Impairment (2022 - 2025) Analysis & Trends

Shattuck Labs (STTK) has reported Asset Writedowns and Impairment for 4 consecutive years, with $81000.0 the latest figure, recorded in Q4 2025.

  • In Q4 2025, Asset Writedowns and Impairment rose 8.0% year-over-year to $81000.0; the TTM figure through Dec 2025 stood at $156000.0 (down 58.73% YoY), while the FY2025 annual figure was $81000.0, down 63.51% from the prior year.
  • Asset Writedowns and Impairment grew to $81000.0 in Q4 2025 per STTK's latest filing, from $75000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $400000.0 in Q2 2022 and bottomed at $75000.0 in Q4 2024.
  • Historically, Asset Writedowns and Impairment has averaged $209833.3 across 4 years, with a median of $151500.0 in 2023.
  • Annual changes were most pronounced in 2023 — Asset Writedowns and Impairment slumped 49.0% — and 2025, when it rose 8.0%.
  • Shattuck Labs' Asset Writedowns and Impairment stood at $400000.0 in 2022, then sank by 75.25% to $99000.0 in 2023, then decreased by 24.24% to $75000.0 in 2024, then advanced by 8.0% to $81000.0 in 2025.
  • Business Quant data shows STTK's Asset Writedowns and Impairment at $81000.0 in Q4 2025, $75000.0 in Q4 2024, and $99000.0 in Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Shattuck Labs 885.09 Mn 885.09 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 81,000.00
Dec 31, 2024 75,000.00
Dec 31, 2023 99,000.00
Sep 30, 2023 204,000.00
Sep 30, 2022 400,000.00
Jun 30, 2022 400,000.00